Efficacy and safety of inhaled nitrite in addition to sildenafil in thalassemia patients with pulmonary hypertension: A 12-week randomized, double-blind placebo-controlled clinical trial
Open Access
- 10 January 2022
- journal article
- research article
- Published by Elsevier in Nitric Oxide
- Vol. 120, 38-43
Abstract
No abstract availableKeywords
Funding Information
- Cooley's Anemia Foundation
This publication has 19 references indexed in Scilit:
- Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemiaBritish Journal of Haematology, 2015
- Prevalence and Risk Factors for Pulmonary Arterial Hypertension in a Large Group of β-Thalassemia Patients Using Right Heart CatheterizationCirculation, 2014
- Decreased nitrite levels in erythrocytes of children with β-thalassemia/hemoglobin ENitric Oxide, 2013
- Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertensionHaematologica, 2013
- Low-dose sodium nitrite vasodilates hypoxic human pulmonary vasculature by a means that is not dependent on a simultaneous elevation in plasma nitriteAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Nitrite Potently Inhibits Hypoxic and Inflammatory Pulmonary Arterial Hypertension and Smooth Muscle Proliferation via Xanthine Oxidoreductase–Dependent Nitric Oxide GenerationCirculation, 2010
- Nitric Oxide and Arginine Dysregulation: A Novel Pathway to Pulmonary Hypertension in Hemolytic DisordersCurrent Molecular Medicine, 2008
- Global epidemiology of haemoglobin disorders and derived service indicatorsBulletin of the World Health Organization, 2008
- Hemolysis‐Associated Pulmonary Hypertension in ThalassemiaAnnals of the New York Academy of Sciences, 2005
- Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilatorNature Medicine, 2004